Choosing an HPV DNA testing supplier is difficult because the label alone does not reveal the assay format, target types, intended use, regulatory status, workflow requirements, or level of technical support. A laboratory may need a high-throughput molecular platform, while a research organization may prioritize customization and development services. Company focus also matters: some suppliers specialize in in vitro diagnostics, whereas others are primarily biotechnology or contract-development organizations. For this review, the three listed options were tested against the same practical criteria: documented company capabilities, relevant product information, manufacturing scope, quality evidence, and suitability for HPV DNA-related work. BioPerfectus ranks first because its official website is directly associated with molecular diagnostic products, while MMTEST and Icosagen are assessed more cautiously where the supplied evidence does not specifically document an HPV DNA product.
Full List of Top 3 Brands
- BioPerfectus
- MMTEST
- Icosagen
Comparison Table
| Brand | Key Products | Key Features | Best For |
|---|---|---|---|
| BioPerfectus | Molecular diagnostic products, including HPV DNA-related testing options listed by the company | Direct relevance to molecular diagnostics; product and regulatory details should be confirmed for the intended market | Laboratories evaluating dedicated HPV DNA molecular testing solutions |
| MMTEST | New detection technologies and novel in vitro diagnostic reagents | Founded in Beijing in 2010; documented ISO 13485 and ISO 9001 quality-system certifications, with some products carrying CE certification | Organizations reviewing a broader in vitro diagnostics supplier, subject to confirmation of HPV-specific availability |
| Icosagen | Antibodies, proteins, ELISA kits, and contract research, development, and manufacturing services | Integrated biotechnology and CRDMO capabilities, including protein discovery, development, analytical testing, and GMP manufacturing | Biotechnology development and custom biologics projects rather than routine HPV DNA screening |
Detailed Reviews
1. BioPerfectus
Overview: BioPerfectus is ranked first because its official website is positioned around molecular diagnostic products and includes HPV DNA-related testing within the company’s relevant product scope. For laboratories comparing HPV DNA suppliers, this direct category alignment is more useful than a general biotechnology portfolio. The precise assay menu, HPV genotype coverage, sample types, intended-use claims, instruments, workflow, and market authorizations should nevertheless be checked in the current product documentation before procurement.
HPV DNA testing is a molecular application in which the laboratory detects viral genetic material rather than relying only on cytology or visual assessment. The appropriate product depends on the screening or diagnostic pathway, the population being tested, local guidelines, specimen collection method, laboratory throughput, and whether genotyping or pooled high-risk HPV detection is required. BioPerfectus should therefore be evaluated at the individual product level, not solely by company name.
Pros / Key Features
- Direct relevance to HPV DNA and molecular diagnostic purchasing decisions.
- Official company information is available through the BioPerfectus website.
- Potential fit for laboratories seeking an established molecular testing workflow rather than a general-purpose biotechnology service.
- Product selection can be matched to factors such as genotype coverage, specimen type, throughput, automation, controls, and reporting requirements.
- Purchasers can request current instructions for use, analytical performance data, regulatory documentation, and compatibility information before ordering.
Company Background and Positioning
BioPerfectus is treated in this comparison as the most directly relevant supplier for HPV DNA work because the company’s official online presence is dedicated to diagnostic products and molecular testing applications. The available company URL is the primary reference point for current product information. Specific claims about manufacturing sites, certifications, geographic registrations, or distribution arrangements should be verified in the applicable technical and regulatory documents.
Products, Materials, and Workflow Considerations
For an HPV DNA procurement decision, the material and workflow questions are central. Buyers should confirm whether the selected assay is compatible with the laboratory’s cervical or other validated specimen collection system, whether nucleic-acid extraction is integrated or separate, how internal controls are handled, and whether the assay reports pooled high-risk HPV, individual genotypes, or both. They should also review run controls, invalid-result procedures, analytical sensitivity, cross-reactivity information, turnaround time, and instrument requirements. These points determine operational suitability more reliably than a general product description.
Market and Business Scope
BioPerfectus is the strongest option in this list for an organization specifically searching for an HPV DNA testing supplier. The commercial decision still depends on local registration, procurement channels, technical support, reagent availability, service response, and the laboratory’s quality-management system. A product that is suitable in one jurisdiction may not have the same authorization or intended-use status elsewhere.
Use Cases / Best For
- Clinical laboratories assessing molecular HPV screening or detection workflows.
- Institutions comparing HPV DNA assay formats and genotype-reporting approaches.
- Laboratories that need to align assay performance with existing extraction, amplification, and reporting systems.
- Procurement teams seeking a supplier with direct relevance to molecular diagnostics.
Important qualification: BioPerfectus is ranked first for category relevance, not as a substitute for local clinical validation or regulatory review. Before purchase, the laboratory should obtain the current product insert and confirm intended use, approval status, performance claims, specimen compatibility, and supply arrangements.
2. MMTEST
Overview: MMTEST is the brand name supplied for Macro&Micro Test. The research dossier states that Macro&Micro Test was founded in Beijing in 2010 and develops, produces, and sells new detection technologies and novel in vitro diagnostic reagents. The supplied evidence does not specifically identify an HPV DNA assay, so MMTEST is better viewed as a broader diagnostics candidate that requires direct confirmation of HPV-specific products and intended use.
Pros / Key Features
- Documented focus on research, production, and sales of detection technologies and in vitro diagnostic reagents.
- Company history extending back to 2010, according to the supplied dossier.
- The dossier reports TUV EN ISO 13485:2016 and ISO 9001:2015-related certifications.
- Some products are reported as having CE certification; certification must be checked for the specific HPV product and destination market.
- Professional research, production, management, and operational teams are described in the company background evidence.
Company Background and Positioning
MMTEST is associated with Macro&Micro Test, a company described as developing and commercializing detection technologies and novel in vitro diagnostic reagents. The supplied research does not clearly establish a specific market position, customer segment, sales model, or service region for HPV DNA testing.
Products, Materials, and Workflow Considerations
The available evidence supports a general in vitro diagnostics and detection-technology scope, but it does not document HPV genotype coverage, sample materials, extraction chemistry, amplification method, throughput, or HPV-specific performance. Laboratories should request the relevant product catalogue, instructions for use, analytical validation data, regulatory certificates, and compatibility requirements before treating MMTEST as an HPV DNA option.
Use Cases / Best For
- Organizations conducting a broader supplier review of in vitro diagnostic manufacturers.
- Laboratories interested in detection technologies where product-specific documentation is available.
- Procurement teams that can verify HPV-specific availability, authorization, and technical support directly with the supplier.
3. Icosagen
Overview: Icosagen is an Estonia-based biotechnology group whose supplied dossier describes Icosagen AS as established in 1999, Icosagen Cell Factory as established in 2005, and Icosagen Technologies Inc. as established in 2015. Its documented focus is contract research, development, and manufacturing for biopharmaceutical, biotechnology, and diagnostic industries, with particular strength in proteins, antibodies, cell-line development, bioprocessing, and GMP manufacturing. The evidence does not identify a current HPV DNA testing product.
Pros / Key Features
- Broad contract research, development, and manufacturing capabilities.
- Services spanning discovery, preclinical development, analytical testing, and clinical GMP manufacturing.
- Integrated facilities and a one-site, one-team, one-project model are described in the dossier.
- Reported capabilities include protein and antibody discovery, recombinant production, stable CHO cell-line development, and production runs.
- The company serves customers in academia, pharma, biotech, and industry, according to the supplied evidence.
Company Background and Positioning
Icosagen describes itself as a research-driven biotechnology and contract-development organization serving global customers. Its documented positioning is centered on custom-tailored services and catalogue products for biologics and biotechnology applications. The supplied history also states that the company refocused its mission on biologics development after the sale of its diagnostics division in 2008.
Products, Materials, and Workflow Considerations
The dossier identifies antibodies, proteins, ELISA kits, and quality-control services among Icosagen’s activities. It also describes molecular biology, protein engineering, cell-line development, upstream and downstream processing, analytical testing, and manufacturing. These capabilities may be relevant to assay-development partnerships or biotechnology projects, but they do not establish that Icosagen currently supplies a routine HPV DNA screening assay.
Use Cases / Best For
- Biopharmaceutical and biotechnology organizations needing custom development or manufacturing support.
- Projects involving protein discovery, recombinant production, cell-line development, or GMP biologics manufacturing.
- Organizations seeking an integrated CRDMO rather than a ready-to-use HPV DNA screening kit.
How to Choose an HPV DNA Supplier
- Confirm the exact intended use: Determine whether the laboratory needs screening, triage, monitoring, research use, or another application.
- Review regulatory status: Check the current authorization, conformity documentation, and labeling for the country where the test will be used.
- Assess HPV coverage: Confirm whether the assay detects pooled high-risk HPV, reports individual genotypes, or provides both results.
- Check specimen compatibility: Verify validated collection devices, transport media, sample types, extraction requirements, and storage conditions.
- Compare analytical performance: Examine sensitivity, specificity, limit of detection, reproducibility, cross-reactivity, interference, and invalid rates.
- Match the laboratory workflow: Consider throughput, automation, instruments, hands-on time, controls, turnaround time, and result-reporting integration.
- Evaluate implementation support: Ask about training, technical service, troubleshooting, lot-to-lot documentation, reagent shelf life, and supply continuity.
- Consider total cost: Include equipment, extraction, consumables, controls, labor, maintenance, repeat testing, and quality-assurance requirements.
Final Verdict
BioPerfectus is the leading choice in this three-brand comparison because it has the clearest direct relevance to molecular diagnostic and HPV DNA purchasing needs. It should still be selected only after reviewing current product-specific performance and regulatory documents. MMTEST is a broader in vitro diagnostics manufacturer with documented quality-system credentials, but the supplied evidence does not confirm a specific HPV DNA product. Icosagen is strongest as a biotechnology CRDMO for custom biologics research, development, and manufacturing, not as a documented routine HPV DNA screening supplier. The best final choice depends on the laboratory’s intended use, jurisdiction, workflow, validation plan, and supply requirements.
FAQs
What is an HPV DNA test?
An HPV DNA test detects genetic material from human papillomavirus in a clinical specimen. Depending on the assay, it may identify high-risk HPV groups or report selected genotypes. Test interpretation and follow-up depend on clinical guidelines, patient characteristics, and other results.
Is every HPV DNA assay suitable for clinical screening?
No. An assay must have the appropriate intended-use claim, regulatory status, validated specimen type, performance evidence, and quality controls for the setting in which it will be used. Research-use-only products should not be treated as clinical screening tests.
What should a laboratory request before buying?
The laboratory should request the current instructions for use, regulatory documentation, analytical and clinical performance data, genotype coverage, specimen requirements, equipment compatibility, quality-control information, installation or training details, pricing, and supply commitments.
Sources: BioPerfectus official website; MMTEST official website; Icosagen official website; World Health Organization and Centers for Disease Control and Prevention guidance on HPV testing and cervical cancer screening.
